Fundraising FoxSevion Therapeutics
San Diego, US · Delaware corporation
Find your way into Sevion Therapeutics
Sign up to see every warm intro you have to Sevion Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sevion Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MA
Miguel A. de los RiosVice President of Research & Development2014–2018Miguel de los Rios founded Chimeros, Inc., a biologics company, in 2003 while completing his PhD in Biophysical Chemistry from UC Santa Barbara. He has held R&D and leadership roles at multiple therapeutic companies including Rift Biotherapeutics and Sevion Therapeutics, with published research across biologics and oncology.
VS
Vaughn SmiderExecutive
DR
David RectorExecutive
JG
James GrazianoExecutive
Board
PF
Phillip FrostBoard director
SR
Steven RubinBoard director
JB
John BracaBoard director
HW
Harlan W. WaksalBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2015
▶$3MraisedMay 2015 · 14 investors · BiotechnologyRule 506(b)
▶$3MraisedMay 2015 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel A. de los RiosExecutive Officer
- Vaughn SmiderExecutive Officer, Director
- John BracaDirector
- Phillip FrostDirector
- Joel BrooksExecutive Officer
- David RectorExecutive Officer, Director
- Steven RubinDirector
- Harlan W. WaksalDirector
- James GrazianoExecutive Officer
- Offering amount
- $10M
- Amount sold
- $3M
- Minimum investment
- $25K
- Sales commissions
- $190.5K
- Placement agents
- Axiom Capital Management, Inc., Laidlaw & Company (UK), Ltd., Newport Coast Securities, Inc., Palladium Capital Advisors, LLC
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Sevion Therapeutics raised?
- Sevion Therapeutics has disclosed $3M raised across 1 round.
- Where is Sevion Therapeutics headquartered?
- Sevion Therapeutics is headquartered in San Diego, US.